Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. Tsai is active.

Publication


Featured researches published by C. Tsai.


Medical Physics | 2010

SU‐GG‐T‐33: An Investigation on the Acquisition and Modification of Cone‐Beam Computed Tomography Images for Head and Neck Cancer

C Hu; Jian-Kuen Wu; H Chao; C. Tsai; C Wang; Jie-Zhi Cheng

Purpose: To determine the optimal parameters in the acquisition of cone‐beam computed tomography(CBCT) for good image quality and to modify the CT numbers for accurate dose calculation in head and neck cancer.Method and Materials: Systems of fan‐beam CT (FBCT) and CBCT were used to acquire images. A program was developed to establish the averaged CT numbers for different materials, and plot them as a function of density. CT numbers of CBCT were modified to match those of FBCT. The modified CBCTimages were used for dose calculation. Three CT phantoms were scanned by FBCT and CBCT for image uniformity, spatial resolution,CT numbers, and for comparing doses from orthogonal beams. A Rando phantom was scanned for head and neck regions by both FBCT and CBCT, and planned with intensity modulated radiation therapy(IMRT). In addition, the CBCTimages at the first and sixth weeks of radiotherapy of a nasopharyngeal cancer patient treated with an IMRT plan were calculated for dose comparison. Results: With 360°acquisition of CBCTimages, and high‐resolution reconstruction, the uniformity of CT number distribution was improved and the otherwise large variations of CT numbers for background and high‐density materials were reduced significantly. The dose difference between FBCT and CBCT was <2% in CT phantoms. In both the Rando phantom and the patient, the dose‐volume histograms were similar between FBCT and CBCT. The corresponding isodose curves covering 90% of the prescribed dose on FBCT and CBCT were within 2 mm. The dosimetric difference on CBCTimages between the first and sixth weeks were more from the setup errors due to body weight loss. Conclusion: The protocol developed for CBCT acquisition and modification produced good quality images which can be used in dose calculation for re‐planning purposes.


Medical Physics | 2009

Poster — Wed Eve—41: VMAT for Prostate Cancer: Superior Organ Sparing to IMRT and Delivery Efficiency to Helical Tomotherapy

Jie-Zhi Cheng; J‐K Wu; C. Tsai; H‐L Chao; Y‐C Tsai

Volumetric modulated arc therapy (VMAT) has been developed for the better dose conformity and shorter treatment time. This study is aimed to compare the dosimetric and treatment parameters between step‐and‐shoot intensity modulated radiation therapy(IMRT), helical tomotherapy (HT), and volumetric modulated arc therapy (VMAT). Eight patients with localized prostate cancer with the dosimetric plans of 5‐field IMRT, HT, and VMAT for their 78‐Gy definitive treatment formed the basis of the study. Treatment target was prostate and proximal seminal vesicles. The goals were minimum clinical target volume (CTV) dose ≥ 78Gy, and 95% of planning target volume (PTV) ≥ 78Gy in 39 fractions. Target comparison showed PTV V95% of 99.95±0.05% for VMAT, 99.84±0.21% for IMRT, and 99.39±0.49% for HT; maximum dose to PTV was 82.44±0.29Gy, 82.45±0.54Gy, 82.80±0.72Gy, respectively. The rectum V65Gy was 11.18±1.52% for VMAT, 13.77±1.68% for IMRT, and 8.44±1.13% for HT, respectively. The bladder V65Gy was 13.25±8.22% for VMAT, 16.51±11.05 % for IMRT, and 10.63±4.47% for HT, respectively. Total monitor units were 304.3±42.3 for VMAT, 335.8±19.0 for IMRT, and 3073.4±532.6 for HT, respectively. Treatment time was 2.47±0.10 minutes for VMAT, 3.71±0.29 minutes for IMRT, and 3.64±0.60 minutes for HT, respectively. The VMAT plans in all 8 patients met the quality assurance criteria of 3% and 3mm. In conclusion, VMAT is a practical technique with comparable target coverage, better organ sparing than IMRT, and superior treatment efficiency to HT in prostate cancer patients.


International Journal of Radiation Oncology Biology Physics | 2012

Intensity Modulated Radiation Therapy for T4 Nasopharyngeal Carcinoma: Treatment Outcomes, Patterns of Recurrence, and Feasibility of Salvage Treatment for Locoregional Recurrence

Jyh-Yih Chen; Sow-Hsong Kuo; C. Tsai; Jun-Jack Cheng; Wang Ch


Offshore Technology Conference | 1979

Mechanisms Of Rapid Cooling And Their Design Considerations In Underwater Welding

C. Tsai; K. Masubuchi


International Journal of Radiation Oncology Biology Physics | 2016

M1a Nodal Involvement and Induction Taxane-Based Chemotherapy Before Neoadjuvant Chemoradiation Therapy Are Associated With Survival Outcomes in Pathological Complete Responder After Trimodality Treatment for Esophageal Squamous Cell Carcinoma

S.L. Lu; Feng-Ming Hsu; C. Tsai; Jang-Ming Lee; Pei-Ming Huang; Chih-Hung Hsu; C. Lin; Yih-Leong Chang; Min-Shu Hsieh; Jen-Kun Cheng


International Journal of Radiation Oncology Biology Physics | 2016

Preclinical Study on Radiosensitization by Combining a Novel Drug Lipotecan With Radiation Therapy in Hepatocellular Carcinoma

Jen-Kun Cheng; Wei-Lin Liu; C. Tsai; Feng-Ming Hsu


Annals of Oncology | 2015

143OHigh anus preservation and low toxicity rates in a phase I trial of neoadjuvant bowel-sparing IMRT/bevacizumab/FOLFOX and TME for locally advanced rectal cancer

Jen-Kun Cheng; Jin-Tung Liang; C. Tsai; Ji-Shiang Hung; John Huang; Yi-Ling Lin; C.-C. Wang


International Journal of Radiation Oncology Biology Physics | 2014

Clinical Application of the Seventh UICC-AJCC TNM Staging System in Patients Treated With Trimodality Therapy for Esophageal Squamous Cell Carcinoma

Feng-Ming Hsu; C. Tsai; Ying-Feng Chang; Jih-Hsiang Lee; Min-Shu Hsieh; Pei-Ming Huang; C. Lin; C. Hsu; Jun-Jack Cheng


International Journal of Radiation Oncology Biology Physics | 2014

Serum Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Can Predict Pathological Response and Disease-Free Survival of Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy

Yun Chiang; Jun-Jack Cheng; Madeline Sydney Graber; Feng-Ming Hsu; C. Tsai; Jih-Hsiang Lee; D.T. Chang; A. Koong


International Journal of Radiation Oncology Biology Physics | 2013

Nondosimetric Biomarker of Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Predicts Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Combined Modality Therapy

S. Lu; C. Tsai; Jingshown Wu; Feng-Ming Hsu; A. Koong; Jun-Jack Cheng

Collaboration


Dive into the C. Tsai's collaboration.

Top Co-Authors

Avatar

Jen-Kun Cheng

Mackay Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Feng-Ming Hsu

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Jingshown Wu

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Jun-Jack Cheng

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Wang Ch

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

C. Lin

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

H. Chao

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jie-Zhi Cheng

National Taiwan University

View shared research outputs
Top Co-Authors

Avatar

Jih-Hsiang Lee

National Taiwan University

View shared research outputs
Researchain Logo
Decentralizing Knowledge